Skip to Content

Tag: ExceleraRx


In brief: Invacare sticks to target, Quality Biomedical takes on investor

September 13, 2019HME News Staff

ELYRIA, Ohio - Invacare reaffirmed its long-term target of $85 million to $105 million adjusted EBITDA run-rate by the fourth quarter of 2020 at the Baird Global Healthcare Conference in New York on Sept. 4. Invacare's Matt Monaghan said the company expects to achieve the goal through a combination of net sales growth driven by new product introductions, supply chain actions to expand gross margin and cost-optimization initiatives to meaningfully reduce SG&A expense. “After four years...

Carolina's Home Medical Equipment, ExceleraRx, Invacare, National Seating & Mobility (NSM), Quality Biomedical, WellSky

Read Full Articlered right arrow icon

Also Noted

ExceleraRx launches home infusion solution

September 11, 2019HME News Staff

MINNEAPOLIS - ExceleraRx has launched Excelera Home Infusion Solutions, a new consulting, project management and revenue cycle management solution that enables health systems to build and manage a home infusion pharmacy. The program offers a blueprint and playbook for building an infusion pharmacy, with topics ranging from ongoing management of clean rooms to project management to payer contracting. "With our extensive experience building and operationalizing point-of-care specialty pharmacies for...

Excelera Home Infusion Solutions, ExceleraRx

Read Full Articlered right arrow icon